statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises

Shares Fell More Than 4% on Thursday

 Source: TradingView.com

 Key TakeawaysEli Lilly shares dropped more than 4% on Thursday as investors assessed the possible impact of a promising...

Novo Nordisk Shares Decline Amid Competitive Pressure

Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
read more...

Why Viking's Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks

picture alliance / Contributor / Getty Images

 Key TakeawaysEli Lilly and Novo Nordisk shares lost ground Thursday, while shares of Viking Therapeutics soared after the company reported...

An Ozempic rival is getting closer to market   and it's hurting Novo Nordisk and Eli Lilly stock

Shares of Novo Nordisk and Eli Lilly slid Thursday after San Diego-based Viking Therapeutics announced that it's advancing an experimental weight loss drug to a late-stage clinical trial.Read more...

Top Stock Movers Now: Molina Healthcare, Ford, Honeywell, and More

Angus Mordant / Bloomberg / Getty Images

 Key TakeawaysU.S. equities were higher at midday Thursday following a report showing the U.S. economy grew more than expected in the second...

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk...

Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial

It brings the drugmaker one step closer to joining the market for GLP-1s, which analysts say could grow into a $150 billion market by the end of the decade...

Wall Street suffered its worst losses since October 2022 on Wednesday, with major indexes plunging, as trader. This negative sentiment carried over into Thursday's pre-market trading, as investors digested disappointing earnings from tech giants.While the broader market was under pressure, retail investor sentiment diverged among the top 5 trending stocks on Stocktwits before the opening bell.1. Viking Therapeutics Inc. (VKTX): VKTX shares surged 18% pre-market to $59.50. The company reported a smaller-than-expected Q2 loss and promising obesity drug trial results, prompting it to advance the drug to Phase 3 development. A bullish analyst rating from Raymond James fueled investor optimism. While sentiment on Stocktwits was neutral (48/100), investors see VKTX as a potential competitor to obesity drug market leaders Novo Nordisk and Eli Lilly. However, the company's widening losses tempered some enthusiasm.<figure class="image"><img style="aspect-ratio:1326/312;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/01_VKTX_premarket_sentiment_score_Jul_25_5b4994ded0.png" alt="01 VKTX premarket sentiment score Jul 25.png" width="1326" height="312"><figcaption>VKTX premarket sentiment score Jul 25</figcaption></figure>2. NVIDIA Corp. (NVDA): After a 6.80% dive on Wednesday, Wall Street darling NVDA shares were down nearly 1% at $113.20 premarket. Despite the overall tech downturn, retail investors remained neutral (50/100) on Stocktwits. Bulls cited Nvidia's AI chip dominance and plans to ship $210 billion worth of its latest Blackwell “GB200” AI servers next year. Recent price-target hikes from analysts also boosted sentiment. Investors await the company's Q2 results next month for a clearer picture.<figure class="image"><img style="aspect-ratio:1322/310;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/02_NVDA_premarket_sentiment_score_Jul_25_4dbd1fb83e.png" alt="02 NVDA premarket sentiment score Jul 25.png" width="1322" height="310"><figcaption>NVDA premarket sentiment score Jul 25</figcaption></figure>3. American Airlines Group Inc. (AAL): Shares plummeted 7.57% to $9.29 premarket, following a nearly 3% decline the previous session. While AAL reported better-than-expected adjusted EPS of $1.09, sales missed estimates by $30 million. The company cut its annual profit forecast due to uneven <a href="https://stocktwits.com/news/markets/equity/american-airlines-southwest-airlines-earnings-preview/c7r4DWHRb3">demand and overcapacity</a>, dampening investor enthusiasm. Stocktwits sentiment was bearish (29/100) amid high chatter. Recent downgrades from analysts and mixed earnings from competitors also weighed on the stock.<figure class="image"><img style="aspect-ratio:1322/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/03_AAL_premarket_sentiment_score_Jul_25_f829426070.png" alt="03 AAL premarket sentiment score Jul 25.png" width="1322" height="306"><figcaption>AAL premarket sentiment score Jul 25</figcaption></figure>4. Ford Motor Co. (F): After missing second-quarter profit estimates due to quality costs and EV competition, Ford shares fell 13.46% to $11.83 premarket. Surprisingly, retail investor sentiment on Stocktwits was bullish (74/100), driven by CEO Jim Farley's optimistic outlook on growth and value creation. Some bullish watchers also highlighted the company's upbeat operating profit guidance for the second half of the year.<figure class="image"><img style="aspect-ratio:1318/316;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/04_F_premarket_sentiment_score_Jul_25_f0cb67ae3f.png" alt="04 F premarket sentiment score Jul 25.png" width="1318" height="316"><figcaption>F premarket sentiment score Jul 25</figcaption></figure>5. Tesla, Inc. (TSLA): Following a 12% <a href="https://stocktwits.com/news/markets/equity/rivian-lucid-retail-sentiment-crashes-after-tesla-q2-results/c7rI3crRb9">crash on Wednesday</a>, TSLA shares were down 1.12% to $213.61 premarket. Stocktwits sentiment was bearish (30/100) as investors questioned CEO Elon Musk's AI-focused strategy amid thinning margins and EPS misses. While some analysts maintained bullish ratings, others expressed concerns about valuation, lack of vehicle-specific details, and potential regulatory hurdles for autonomous vehicles. A series of downgrades from Wall Street analysts further dampened sentiment. KGI Securities and Barclays downgraded the stock, while Bernstein said TSLA results underscore ongoing challenges and Roth sees “dampened investor expectations” on Tesla after Q2.<figure class="image"><img style="aspect-ratio:1324/310;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/05_TSLA_premarket_sentiment_score_Jul_25_8ed07c90a6.png" alt="05 TSLA premarket sentiment score Jul 25.png" width="1324" height="310"><figcaption>TSLA premarket sentiment score Jul 25</figcaption></figure>Photo courtesy: Vecteezy

Viking Therapeutics, Nvidia, American Airlines, Ford, Tesla: Retail Street Bullish Only On 1 Of Top 5 Trending Stocks Premarket

Retail investors are not exactly paying heed to the broader market with regard to some big names, finding most optimism in a legacy auto giant whose earnings were less than impressive.

VKTX, NVDA, AAL, F, TSLA: Retail Street Bullish Only On 1 Of Top 5 Trending Stocks Premarket

Equity

Futures Drop As Japan, European Stocks Tumble On AI Bubble Bursting Fears

Futures Drop As Japan, European Stocks Tumble On AI Bubble Bursting Fears

 US equity futures are lower but well off their worst levels, after a rout in Japan sent the Nikkei tumbling...

Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today...

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Volume	9.3M
52-Wk High	$99.41
52-Wk Low	$8.28

Current Price	$65.98
Prev Close	$64.68
Open	$65.62
Dividend Yield	0.00%
50-Day Moving Average	$56.73
Beta	1.03
Avg. Volume	4.62M
PE Ratio	-70.39

52-Week High	$99.41
52-Week Low	$8.28
Market Capitalization	$7.28B
EPS	-$0.9374
Price to Book	7.94
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	-39.48

VKTX Viking Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals